Cat.#: ACPP-1846
Despition | FGF 9 Human Recombinant |
SIZE | 5 µg |
Purity | > 95.0% by RP-HPLC and SDS-PAGE. |
Form | Sterile Filtered white lyophilized powder. |
Storage | Lyophilized was stored and desiccated below -18°C. |
Shipping | Shipped at 4°C |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ACPP-1650 | Human HSPB8 Protein (AC1650) | 2 µg | inquiry |
ACPP-1669 | Human NRGN Protein (AC1669) | 2 µg | inquiry |
ACPP-1299 | Calretinin Blocking Peptide (AC1299) | 250 µg | inquiry |
ACPP-1418 | Human GAL Protein (AC1418) | 2 µg | inquiry |
ACPP-1204 | P2Y1 Blocking Peptide (AC1204) | 250 µg | inquiry |
ACPP-1017 | Recombinant Human FGF19 Protein (AC1017) | 50 µg | inquiry |
ACPP-1699 | Human Human Prealbumin (Active) Protein (AC1699) | 1 mg | inquiry |
ACPP-1368 | KCNJ2 Blocking Peptide (AC1368) | 250 µg | inquiry |
ACPP-1096 | Synthetic Nanodisc Human CXCR4 Protein (AC1096) | 10 µg | inquiry |
ACPP-1518 | Human MANF Protein, His (AC1518) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.